Healthcare · Drug Manufacturers Specialty Generic · NASDAQ
Harrow, Inc. (HROW) is a Healthcare company in the Drug Manufacturers Specialty Generic industry. It has a market capitalization of $1.51B and a free-cash-flow yield of 2.9%. Over the most recent reported fiscal year, revenue grew 36.4%.